81 related articles for article (PubMed ID: 3566295)
1. [Spergualin, a new antitumor antibiotic].
Takeuchi T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
[TBL] [Abstract][Full Text] [Related]
2. Spergualin: a new antitumour antibiotic.
Umezawa K; Takeuchi T
Biomed Pharmacother; 1987; 41(5):227-32. PubMed ID: 3499181
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
5. [Spergualin a novel antitumor antibiotic produced by Bacillus laterosporus].
Takeuchi T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2633-9. PubMed ID: 6508320
[TBL] [Abstract][Full Text] [Related]
6. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
7. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety.
Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Fujii A; Iinuma H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 Sep; 40(9):1303-15. PubMed ID: 3680040
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety.
Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Iinuma H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jul; 38(7):886-98. PubMed ID: 4030502
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
Iwasawa H; Kondo S; Ikeda D; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Dec; 35(12):1665-9. PubMed ID: 6926749
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
12. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
[TBL] [Abstract][Full Text] [Related]
14. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells].
Ishida N; Saito M; Nanjo M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
Guo QL; Wu MS; Chen Z
Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
[TBL] [Abstract][Full Text] [Related]
16. Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
Nishikawa K; Shibasaki C; Hiratsuka M; Arakawa M; Takahashi K; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1101-9. PubMed ID: 1955393
[TBL] [Abstract][Full Text] [Related]
17. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
Rose WC; Schurig JE; Huftalen JB; Bradner WT
Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
[No Abstract] [Full Text] [Related]
18. LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells.
Takahashi M; Ogasawara K; Takeda K; Hashimoto W; Sakihara H; Kumagai K; Anzai R; Satoh M; Seki S
J Immunol; 1996 Apr; 156(7):2436-42. PubMed ID: 8786302
[TBL] [Abstract][Full Text] [Related]
19. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of spergualin analogues. III. Novel method for synthesis of optically active 15-deoxyspergualin and 15-deoxy-11-O-methylspergualin.
Umeda Y; Moriguchi M; Ikai K; Kuroda H; Nakamura T; Fujii A; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 Sep; 40(9):1316-24. PubMed ID: 3680041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
